NICE: Real-World Evidence Revolution Will Drive UK’s Health Care Innovation
Decision-makers will have more data on which to judge the value of innovative medtech and healthtech products
Executive Summary
In its just-released real-world evidence framework, NICE assesses the role and value of data collected outside highly-controlled clinical studies in driving more innovation towards health care professionals.
You may also be interested in...
Here Comes The NICE Revolution – Agility And Speed Will Drive UK HTA Into A New Era
Evolving health care demands, digital innovation and the need to work within tighter budgets have prompted the UK’s NICE to reset its strategy for the coming five years.
Medtech’s Role In The Carbon Neutral Challenge To Counter Climate Change – The UK View
“Sustainability executive” is a new job role for a new era. The UK’s largest healthtech industry association has appointed one, and many medtech companies in every geography might eventually do likewise, as the drive for nations to achieve carbon neutrality picks up pace. Medtech Insight spoke to the ABHI’s new incumbent Addie MacGregor and director of value and access Luella Trickett to gauge the size of the task before the medtech industry.
‘Patchy’ UK AHSNs To Be Addressed Ahead Of 2023 Relicensing
A new remit for the NHS’ innovation vehicles, hopes for Integrated Care Systems and a new diagnostics trends report from Deloitte were on the agenda at a UK life sciences sector policy conference.